A patent review of adenosine A 2B receptor antagonists (2016-present).
Beatrice FrancucciDiego Dal BenCatia LambertucciAndrea SpinaciRosaria VolpiniGabriella MarucciMichela BuccioniPublished in: Expert opinion on therapeutic patents (2022)
ARs drugs. Although several compounds have been synthesized only a few molecules have entered clinical trials.